VentureLabs alumni company, Aspect Biosystems raises US$115 million Series B financing
Aspect Biosystems successfully raised US$115 million Series B financing to proceed with bioprinted tissue therapeutics development. Aspect Biosystems is a biotechnology company that is developing technology to help incurable diseases…
VentureLabs 2024 Recap
VentureLabs’ year in review is a celebration of our successes and an opportunity to reflect on our support services for the innovation community. In 2024, we brought in more intellectual…
From a Father’s Fear to a Global Vision: The Story of skiKrumb
Imagine skiing down a serene, snow-covered mountain, only to realize your child is missing. For Keith MacIntyre, this terrifying experience became the foundation of skiKrumb – a revolutionary product that…
SFU VentureLabs Member Companies to Attend HealthTech Ignite Conference
FOR IMMEDIATE RELEASE October 10, 2024 Vancouver, BC — SFU VentureLabs is excited to announce three member companies will attend HealthTech Ignite, an annual conference presented by Pender Ventures. This…
SFU VentureLabs Gives Out Prizes to Emerging Startups at Annual New Ventures BC Competition
FOR IMMEDIATE RELEASE September 19, 2024 Vancouver, BC —The vibrant provincial startup and innovation scene was in full swing at the New Ventures BC Competition awards ceremony on Thursday night,…
SFU VentureLabs Company, Spexi, To Speak Alongside City of Vancouver at Conference in Whistler
FOR IMMEDIATE RELEASE September 9, 2024 Vancouver, BC — SFU VentureLabs company, Spexi, is set to speak alongside the City of Vancouver on September 11th as part of the MISA…
Topics
Tags
Events
Leveraging Registered Accounts for Capital Raising & Angel Investing
Osler, Hoskin & Harcourt LLP30
Contact Us
Ready to start a conversation?
Get in touch with us.